This inventor holds 2 USPTO granted patents. Top assignees: Agence Francaise De Securite Sanitaire Des Aliments-Afssa, Centre National De La Recherche Scientifique, Biomerieux, Inc.. Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
2 out of 5,383 
1 out of 645 
Years Active: 2007-2010
Title: Patrick Shahgaldian: Innovator in Prion Detection Technologies
Introduction
Patrick Shahgaldian is a notable inventor based in Lyons, France. He has made significant contributions to the field of prion detection, holding 2 patents that focus on innovative methods for diagnosing prion-related pathologies. His work is crucial in advancing the understanding and detection of prion diseases, which pose serious health risks.
Latest Patents
Shahgaldian's latest patents include a process of concentration by precipitation of PrP for detecting or diagnosing PrP. This method involves bringing a tissue or biological fluid from an animal or human organism together with an antibiotic from the aminoglycoside family, preferably streptomycin or its derivatives. The patent also discloses the use of such an antibiotic for eliminating PrP from a tissue or biological fluid, along with a kit for diagnosing pathologies associated with the presence of PrP. Another significant patent is a process for detecting PrP using a macrocyclic adjuvant ligand. This process involves adding a macrocyclic adjuvant ligand, either free or bound to a support, to a biological sample capable of containing PrP. The resulting suspension is then reacted with an anti-PrP antibody, allowing for the detection of PrP.
Career Highlights
Throughout his career, Patrick Shahgaldian has worked with prominent organizations such as the Agence Française de Sécurité Sanitaire des Aliments (AFSSA) and the Centre National de la Recherche Scientifique (CNRS). His experience in these institutions has greatly contributed to his expertise in prion research and detection technologies.
Collaborations
Shahgaldian has collaborated with notable colleagues, including Aly Moussa and Anthony William Coleman. These partnerships have enhanced his research and development efforts in the field of prion detection.
Conclusion
Patrick Shahgaldian is a distinguished inventor whose work in prion detection technologies is paving the way for advancements in diagnosing prion-related diseases. His innovative patents and collaborations reflect his commitment to improving health outcomes through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile